Abstract
Takayasu’s arteritis is a chronic idiopathic inflammatory large vessel vasculitis affecting mostly young adults. The disease process predominantly involves the aorta and its main branches such as the carotid and subclavian arteries. Vessel wall inflammation leads to stenosis, occlusion, or aneurysmal dilation of involved arteries and subsequent end-organ damage. Clinical presentations vary and range from nonspecific constitutional symptoms to symptoms associated with vascular injury, such as pulselessness, limb claudication, renovascular hypertension, angina, carotidynia, and strokes. In addition to comprehensive clinical assessment, imaging techniques, such as ultrasound, Magnetic Resonance Angiography (MRA), Computed Tomography Angiography (CTA) and Positron Emission Tomography (PET) play a critical role in establishing diagnosis and monitoring disease progression and response to treatment. Therapeutic strategies consist of medical therapy focused on immunosuppressive therapy and more recently, biological-targeted therapy. Endovascular and surgical interventions will also be discussed.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Mason JC. Takayasu arteritis – advances in diagnosis and management. Nat Rev Rheumatol. 2010;6:406–15.
Numano F, Okawara M, Inomata H, Kobayashi Y. Takayasu’s arteritis. Lancet. 2000;356:1023–5.
Terao C. History of Takayasu arteritis and Dr. Mikito Takayasu. Int J Rheum Dis. 2014;17:931–5.
Numano F, Kakuta T. Takayasu arteritis – five doctors in the history of Takayasu arteritis. Int J Cardiol. 1996;54:S1–10.
Weyand CM, Goronzy JJ. Medium- and large-vessel vasculitis. N Engl J Med. 2003;349:160–9.
Johnston SL, Lock RJ, Gompels MM. Takayasu arteritis: a review. J Clin Pathol. 2002;55:481–6.
Gravanis MB. Giant cell arteritis and Takayasu aortitis: morphologic, pathogenetic and etiologic factors. Int J Cardiol. 2000;75(Suppl. 1):S21–33.. discussion S35–6
Kerr GS. Takayasu’s arteritis. Rheum Dis Clin N Am. 1995;21:1041–58.
Subramanyan R, Joy J, Balakrishnan KG. Natural history of aortoarteritis (Takayasu’s disease). Circulation. 1989;80:429–37.
Lupi-Herrera E, Sánchez-Torres G, Marcushamer J, Mispireta J, Horwitz S, Vela JE. Takayasu arteritis. Clinical study of 107 cases. Am Heart J. 1977;93:94–103.
Kerr GS, Hallahan CW, Giordano J, Leavitt RY, Fauci AS, Rotten M, et al. Takayasu arteritis. Ann Intern Med. 1994;120:919–29.
Jain S, Kumari S, Ganguly NK, Sharma BK. Current status of Takayasu arteritis in India. Int J Cardiol. 1996;54(Suppl):S111–6.
Ishikawa K. Natural history and classification of occlusive thromboaortopathy (Takayasu’s disease). Circulation. 1978;57:27–35.
Hall S, Barr W, Lie JT, Stanson AW, Kazmier FJ, Hunder GG. Takayasu arteritis. A study of 32 North American patients. Medicine. 1985;64:89–99.
Lupi E, Sánchez G, Horwitz S, Gutierrez E. Pulmonary artery involvement in Takayasu’s arteritis. Chest. 1975;67:69–74.
Yamada I, Shibuya H, Matsubara O, Umehara I, Makino T, Numano F, et al. Pulmonary artery disease in Takayasu’s arteritis: angiographic findings. AJR Am J Roentgenol. 1992;159:263–9.
Duarte MM, Geraldes R, Sousa R, Alarcao J, Costa J. Stroke and transient ischemic attack in Takayasu’s arteritis: a systematic review and meta-analysis. J Stroke Cerebrovasc Dis. 2016;25:781–91.
Bond KM, Nasr D, Lehman V, Lanzino G, Cloft HJ, Brinjikji W. Intracranial and extracranial neurovascular manifestations of Takayasu arteritis. AJNR Am J Neuroradiol. 2017;38:766–72.
Couture P, Chazal T, Rosso C, Haroche J, Leger A, Hervier B, et al. Cerebrovascular events in Takayasu arteritis: a multicenter case-controlled study. J Neurol. 2018;265:757–63.
Kumral E, Evyapan D, Aksu K, Keser G, Kabasakal Y, Balkir K. Microembolus detection in patients with Takayasu’s arteritis. Stroke. 2002;33:712–6.
Park KC, Kim JH, Yoon SS, Heo SH. Takayasu’s disease presenting with atherothrombotic ischaemic stroke. Neurol Sci. 2008;29:363–6.
Kim HJ, Suh DC, Kim JK, Kim SJ, Lee JH, Choi CG, et al. Correlation of neurological manifestations of Takayasu’s arteritis with cerebral angiographic findings. Clin Imaging. 2005;29:79–85.
Hao R, Zhang J, Ma Z, Xiao M, Zhou L, Kang N, et al. Takayasu’s arteritis presenting with common carotid artery dissection: a rare case report. Exp Ther Med. 2016;12:4061–3.
Skeik N, Rumery KK, Udayakumar PD, Crandall BM, Warrington KJ, Sullivan TM. Concurrent Takayasu arteritis with common variable immunodeficiency and moyamoya disease. Ann Vasc Surg. 2013;27(240):e213–48.
Moriwaki R, Noda M, Yajima M, Sharma BK, Numano F. Clinical manifestations of Takayasu arteritis in India and Japan—new classification of angiographic findings. Angiology. 1997;48:369–79.
Ishikawa K, Maetani S. Long-term outcome for 120 Japanese patients with Takayasu’s disease: clinical and statistical analyses of related prognostic factors. Circulation. 1994;90:1855–60.
Comarmond C, Biard L, Lambert M, Mekinian A, Ferfar Y, Kahn JE, et al. Long-term outcomes and prognostic factors of complications in Takayasu’s arteritis: a multicenter study of 318 patients. Circulation. 2017;136:1114–22.
Ammirati E, Moroni F, Pedrotti P, Scotti I, Magnoni M, Bozzolo EP, et al. Non-invasive imaging of vascular inflammation. Front Immunol. 2014;5:399.
Hartlage GR, Palios J, Barron BJ, Stillman AE, Bossone E, Clements SD, et al. Multimodality imaging of aortitis. JACC Cardiovasc Imaging. 2014;7:605–19.
Prieto-Gonzalez S, Arguis P, Cid MC. Imaging in systemic vasculitis. Curr Opin Rheumatol. 2015;27:5362.
Prieto-Gonzalez S, Espıgol-Frigole G, Garcia-Martinez A, Alba MA, Tavera-Bahillo I, Hernandez-Rodriguez J, et al. The expanding role of imaging in systemic vasculitis. Rheum Dis Clin N Am. 2016;42:733–51.
Tombetti E, Mason JC. Application of imaging techniques for Takayasu arteritis. Presse Med. 2017;46:e215–23.
Gornik HL, Creager MA. Aortitis. Circulation. 2008;117:3039–51.
Maeda H, Handa N, Matsumoto M, Hougaku H, Ogawa S, Oku N, et al. Carotid lesions detected by B-mode ultrasonography in Takayasu’s arteritis: “macaroni sign” as an indicator of the disease. Ultrasound Med Biol. 1991;17(7):695–701.
Schmidt WA, Backhaus M. What the practicing rheumatologist needs to know about the technical fundamentals of ultrasonography. Best Pract Res Clin Rheumatol. 2008;22(6):981–99.
Coli S, Magnoni M, Sangiorgi G, Marrocco-Trischitta MM, Melisurgo G, Mau- riello A, et al. Contrast-enhanced ultrasound imaging of intraplaque neovascularization in carotid arteries: correlation with histology and plaque echogenicity. J Am Coll Cardiol. 2008;52(3):223–30.
Andrews J, Mason JC. Takayasu’s arteritis: recent advances in imaging offer promise. Rheumatology. 2007;46:6–15.
Giordana P, Baque-Juston MC, Jeandel PY, Mondot L, Hirlemann J, Padovani B, et al. Contrast-enhanced ultrasound of carotid artery wall in Takayasu disease: first evidence of application in diagnosis and monitoring of response to treatment. Circulation. 2011;124(2):245–7.
Magnoni M, Dagna L, Coli S, Cianflone D, Sabbadini MG, Maseri A. Assessment of Takayasu arteritis activity by carotid contrast-enhanced ultrasound. Circ Cardiovasc Imaging. 2011;4(2):e1–2.
Lambert M, Hatron PY, Hachulla E, Warembourg H, Devulder B. Takayasu’s arteritis diagnosed at the early systemic phase: diagnosis with noninvasive investigation despite normal findings on angiography. J Rheumatol. 1998;25:376–7.
Khandelwal N, Kalra N, Garg MK, Kang M, Lal A, Jain S, et al. Multidetector CT angiography in Takayasu arteritis. Eur J Radiol. 2011;77(2):369–74.
Yoshida S, Akiba H, Tamakawa M, Yama N, Takeda M, Hareyama M, et al. The spectrum of findings in supra-aortic Takayasu’s arteritis as seen on spiral CT angiography and digital subtraction angiography. Cardiovasc Intervent Radiol. 2001;24(2):117–21.
Park JH, Chung JW, Im JG, Kim SK, Park YB, Han MC. Takayasu arteritis: evaluation of mural changes in the aorta and pulmonary artery with CT angiography. Radiology. 1995;196:89–93.
Matsunaga N, Hayashi K, Sakamoto I, Ogawa Y, Matsumoto T. Takayasu arteritis: protean radiologic manifestations and diagnosis. Radiographics. 1997;17(3):579–94.
Restrepo CS, Ocazionez D, Suri R, Vargas D. Aortitis: imaging spectrum of the infectious and inflammatory conditions of the aorta. Radiographics. 2011;31:435–51.
Yamada I, Nakagawa T, Himeno Y, Numano F, Shibuya H. Takayasu arteritis: evaluation of the thoracic aorta with CT angiography. Radiology. 1998;209(1):103–9.
Kang EJ, Kim SM, Choe YH, Lee GY, Lee KN, Kim DK. Takayasu arteritis: assessment of coronary arterial abnormalities with 128-section dual-source CT angiography of the coronary arteries and aorta. Radiology. 2014;270(1):74–81.
Soto ME, Melendez-Ramirez G, Kimura-Hayama E, Meava-Gonzalez A, Achenbach S, Herrera MC, et al. Coronary CT angiography in Takayasu arteritis. J Am Coll Cardiol Img. 2011;4:958–66.
Hartung MP, Grist TM, Francois CJ. Magnetic resonance angiography: current status and future directions. J Cardiovasc Magn Reson. 2011;13:19.
Keenan NG, Mason JC, Maceira A, Assomull R, O’Hanlon R, Chan C, et al. Integrated cardiac and vascular assessment in Takayasu arteritis by cardiovascular magnetic resonance. Arthritis Rheum. 2009;60:3501–9.
Ramen SV, Aneja A, Jarjour WN. CMR in inflammatory vasculitis. J Cardiovasc Magn Reson. 2012;14:82.
Ishimori T, Saga T, Mamede M, Kobayashi H, Higashi T, Nakamoto Y, et al. Increased (18)F-FDG uptake in a model of inflammation: concanavalin A- mediated lymphocyte activation. J Nucl Med. 2002;43(5):658–63.
Belhocine T, Blockmans D, Hustinx R, Vandevivere J, Mortelmans L. Imaging of large vessel vasculitis with(18)FDG PET: illusion or reality? A critical review of the literature data. Eur J Nucl Med Mol Imaging. 2003;30(9):1305–13.
Hayashida T, Sueyoshi E, Sakamoto I, Uetani M, Chiba K. PET features of aortic diseases. AJR Am J Roentgenol. 2010;195:229–33.
Blockmans D, Bley T, Schmidt W. Imaging for large-vessel vasculitis. Curr Opin Rheumatol. 2009;21:19–28.
Walter MA. [18F]fluorodeoxyglucose PET in large vessel vasculitis. Radiol Clin N Am. 2007;45:735–44.
Lehmann P, Buchtala S, Achajew N, Haerle P, Ehrenstein B, Lighvani H, et al. 18F-FDG PET as a diagnostic procedure in large vessel vasculitis – a controlled, blinded re-examination ofo routine PET scans. Clin Rheumatol. 2011;30:37–42.
Weber DA, Ivanovic M. Correlative image registration. Semin Nucl Med. 1994;24(4):311–23.
Kobayashi Y, Ishii K, Oda K, Nariai T, Tanaka Y, Ishiwata K, et al. Aortic wall inflammation due to Takayasu arteritis imaged with 18F-FDG PET coregistered with enhanced CT. J Nucl Med. 2005;46(6):917–22.
Henes JC, Muller M, Krieger J, Balletshofer B, Pfannenberg AC, Kanz L, et al. [18F] FDG-PET/CT as a new and sensitive imaging method for the diagnosis of large vessel vasculitis. Clin Exp Rheumatol. 2008;26(3 Suppl 49):S47–52.
Einspieler I, Thurmel K, Pyka T, Elber M, Wolfram S, Moog P, et al. Imaging large vessel vasculitis with fully integrated PET/MRI: a pilot study. Eur J Nucl Med Mol Imaging. 2015;42:1012–24.
Grayson PC, Alehashemi S, Bagheri AA, Civelek AC, Cupps TR, Kaplan MJ, et al. 18F-fluorodeoxyglucose-positron emission tomography as an imaging biomarker in a prospective, longitudinal cohort of patients with large vessel vasculitis. Arthritis Rheumatol. 2018;70:439–49.
Papadopoulos V, Baraldi M, Guilarte TR, Knudsen TB, Lacapere JJ, Lindemann P, et al. Translocator protein (18kDa): new nomenclature for the peripheral-type benzodiazepine receptor based on its structure and molecular function. Trends Pharmacol Sci. 2006;27(8):402–9.
Canat X, Guillaumont A, Bouaboula M, Poinot-Chazel C, Derocq JM, Carayon P, et al. Peripheral benzodiazepine receptor modulation with phagocyte differentiation. Biochem Pharmacol. 1993;46(3):551–4.
Pugliese F, Gaemperli O, Kinderlerer AR, Lamare F, Shalhoub J, Davies AH, et al. Imaging of vascular inflammation with [11C]-PK11195 and positron emission tomography/computed tomography angiography. J Am Coll Cardiol. 2010;56(8):653–61.
Wang Y, Yue X, Kiesewetter DO, Niu G, Teng G, Chen X. PET imaging of neuroinflammation in a rat traumatic brain injury model with radiolabeled TSPO ligand DPA-714. Eur J Nucl Med Mol Imaging. 2014;41(7):1440–9.
Arend WP, Michel BA, Bloch DA, Hunder GG, Calabrese LH, Edworthy SM, et al. The American College of Rheumatology 1990 criteria for the classification of Takayasu arteritis. Arthritis Rheum. 1990;33(8):1129–34.
Seeliger B, Sznajd J, Robson JC, Judge A, Craven A, Grayson PC, et al. Are the 1990 American College of Rheumatology vasculitis classification criteria still valid? Rheumatology. 2017;56:1154–61.
Yoshida M, Watanabe R, Ishii T, Machiyama T, Akita K, Fujita Y, et al. Retrospective analysis of 95 patients with large vessel vasculitis: a single center experience. Int J Rheum Dis. 2016;19:87–94.
Hoffman GS, Ahmed AE. Surrogate markers of disease activity in patients with Takayasu arteritis. A preliminary report from The International Network for the Study of the Systemic Vasculitides (INSSYS). Int J Cardiol. 1998;66:S191–4.
Lagneau P, Michel JB, Vuong PN. Surgical treatment of Takayasu’s disease. Ann Surg. 1987;205(2):157–66.
Japanese Circulation Society. Guideline for management of vasculitis syndrome (JCS2008). Japanese Circulation Society. Circ J. 2011;75(2):474–503.
Shelhamer JH. Takayasu’s arteritis and its therapy. Ann Intern Med. 1985;103:121–6.
Hoffman GS, Leavitt RY, Kerr GS, Rottem M, Sneller MC, Fauci AS. Treatment of glucocorticoid-resistant or relapsing Takayasu arteritis with methotrexate. Arthritis Rheum. 1994;37(4):578–82.
Maksimowicz-Mckinnon K, Clark TM, Hoffman GS. Limitations of therapy and a guarded prognosis in an American cohort of Takayasu arteritis patients. Arthritis Rheum. 2007;56:1000–9.
Valsakumar AK, Valappil UC, Jorapur V, Garg N, Nityanand S, Sinha N. Role of immunosuppressive therapy on clinical, immunological, and angiographic outcome in active Takayasu's arteritis. J Rheumatol. 2003;30(8):1793–8.
Youngstein T, Peters JE, Hamdulay SS, Mewar D, Price-Forbes A, Lloy M, et al. Serial analysis of clinical and imaging indices reveals prolonged efficacy of TNF-a and IL-6 receptor targeted therapies in refractory Takayasu arteritis. Clin Exp Rheumatol. 2014;32:S11–8.
Mekinian A, Comarmond C, Resche-Rigon M, Mirault T, Kahn JE, Lambert M, et al. Efficacy of biological-targeted treatments in Takayasu arteritis: multicenter, retrospective study of 49 patients. Circulation. 2015;132:1693–700.
Nakaoka Y, Isobe M, Takei S, Tanaka Y, Ishii T, Yokota S, et al. Efficacy and safety of tocilizumab in patients with refractory Takayasu arteritis: results from a randomised, double-blind, placebo-controlled, phase 3 trial in Japan (the TAKT study). Ann Rheum Dis. 2018;77(3):348–54.
Youngstein T, Mason JC. Interleukin 6 targeting in refractory Takayasu arteritis: serial noninvasive imaging is mandatory to monitor efficacy. J Rheumatol. 2013;40:1941–4.
Tombetti E, Mason J. Takayasu arteritis: advanced understanding is leading to new horizons. Rheumatology (Oxford). 2018;58(2):206–19.
Rao SA, Mandalam KR, Rao VR, Gupta AK, Joseph S, Unni MN, et al. Takayasu arteritis: initial and long-term follow-up in 16 patients after percutaneous transluminal angioplasty of the descending thoracic and abdominal aorta. Radiology. 1993;189(1):173–9.
Ogino H, Matsuda H, Minatoya K, Sasaki H, Tanaka H, Matsumura Y, et al. Overview of late outcome of medical and surgical treatment for Takayasu arteritis. Circulation. 2008;118:2738–47.
Mason JC. Takayasu arteritis: surgical interventions. Curr Opin Rheumatol. 2015;27:45–52.
Perera AH, Youngstein T, Gibbs RG, Jackson JE, Wolfe JH, Mason JC. Optimizing the outcome of vascular intervention for Takayasu arteritis. Br J Surg. 2014;101:43–50.
Saadoun D, Lambert M, Mirault T, Resche-Rigon M, Koskas F, Cluzel P, et al. Retrospective analysis of surgery versus endovascular intervention in Takayasu arteritis: a multicenter experience. Circulation. 2012;125:813–9.
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2020 Springer Nature Switzerland AG
About this chapter
Cite this chapter
Shek, Y., Song, S.S. (2020). Takayasu’s Arteritis. In: Park, M., Kalani, M., de Havenon, A., McNally, J. (eds) Carotid Artery Disease. Springer, Cham. https://doi.org/10.1007/978-3-030-41138-1_16
Download citation
DOI: https://doi.org/10.1007/978-3-030-41138-1_16
Published:
Publisher Name: Springer, Cham
Print ISBN: 978-3-030-41137-4
Online ISBN: 978-3-030-41138-1
eBook Packages: MedicineMedicine (R0)